Filing
Spy
Filing
Spy
Home
About
ZNTL — Zentalis Pharmaceuticals Inc - FilingSpy
ZNTL
Zentalis Pharmaceuticals Inc
Clinical-stage biopharmaceutical company
CUSIP: 98943L107
Healthcare
US
1 holder
Ownership
Activity
2022 Q2
1 of 9 quarters
Total Value
$56.95M
Total Shares
2.03M
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Viking Global Investors
$56.95M
2.03M
0.3%
Unchanged
Viking Global Investors
$56.95M
2.03M shares
Unchanged